Astrana Health, Inc. reiterated earnings guidance for the year ending December 31, 2024. For the year, the company expects total revenue in the range of $1,650.0 million to $1,850.0 million, Net income attributable to Astrana Health, Inc. in the range of $61.0 million to $73.0 million and EPS ? diluted in the range of $1.28 to $1.52.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.9 USD | -0.56% | +5.17% | +6.79% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.79% | 2B | |
+19.28% | 84.56B | |
-26.95% | 72.41B | |
+4.58% | 27.75B | |
-7.35% | 17.75B | |
-0.46% | 17.11B | |
+4.69% | 16.03B | |
+8.14% | 13.72B | |
+69.96% | 13.07B | |
+6.59% | 12.91B |
- Stock Market
- Equities
- ASTH Stock
- News Astrana Health, Inc.
- Astrana Health, Inc. Reiterates Earnings Guidance for the Year Ending December 31, 2024